Immuron Ltd Files 6-K with January Announcements

TL;DR

IMRN filed a 6-K with new announcements, check for details.

AI Summary

Immuron Limited filed a Form 6-K on January 10, 2025, reporting two announcements made during January 2025. The filing is for a foreign private issuer and indicates the company files annual reports under Form 20-F. Specific details of the announcements are not provided in this excerpt.

Why It Matters

This filing provides an update from Immuron Ltd to the SEC, signaling ongoing corporate activities and disclosures relevant to investors.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that reports announcements, not a filing detailing significant financial changes or events.

Key Players & Entities

• Immuron Limited (company) — Registrant
• 001-38104 (company) — SEC File Number
• January 2025 (date) — Reporting period for announcements
• 20250110 (date) — Filing date

FAQ

Filing Documents

• ea0227337-6k_immuron.htm (6-K) — 13KB
• ea022733701ex99-1_immuron.htm (EX-99.1) — 32KB
• ea022733701ex99-2_immuron.htm (EX-99.2) — 8KB
• ex99-1_001.jpg (GRAPHIC) — 2KB
• ex99-2_001.jpg (GRAPHIC) — 15KB
• ex99-2_002.jpg (GRAPHIC) — 7KB
• 0001213900-25-002336.txt ( ) — 87KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of January 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on January 10, 2025 titled: - “Application for quotation of securities - IMC” - “Notice under section 708A” A copy of the Public Notices are attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Application for quotation of securities - IMC 99.2 Notice under section 708A 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: January 10, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR